Annual report
2150.TEDINET S100T58T
Period2023-01-01 → 2023-12-31
Filed2024-03-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥10.2bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥9.3bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥8.0bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.3bn | 2020-01-01 → 2020-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.3bn | 2019-01-01 → 2019-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.4bn | 2023-01-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥2.9bn | 2022-01-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥2.5bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.9bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.6bn | 2021-01-01 → 2021-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2020-01-01 → 2020-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥593m | 2019-01-01 → 2019-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.4bn | 2023-01-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.8bn | 2022-01-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.5bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.8bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.6bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥816m | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥448m | 2019-01-01 → 2019-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.5bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥1.9bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥14.2bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥13.1bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥10.7bn | at 2021-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥5.3bn | at 2020-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥3.1bn | at 2019-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.7bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥3.1bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥11.5bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥10.0bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥8.1bn | at 2021-12-31d | Cons. | Net assets |
| Net assets / equity | ¥3.1bn | at 2020-12-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥2.2bn | at 2019-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.9bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥7.8bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.7bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.7bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.2bn | at 2021-12-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2020-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.3bn | at 2019-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.7bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.8bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.8bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.4bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥278m | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥431m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥303m | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥332m | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥139m | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥288m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥260m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.4bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥47m | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥307m | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥33.9 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.7 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.11 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.64 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.58 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥252.23 | at 2023-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥224.11 | at 2022-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥183.42 | at 2021-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥74.02 | at 2020-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥51.8 | at 2019-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 79.3% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.4% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.6% | at 2021-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.8% | at 2020-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.8% | at 2019-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 14.2% | 2023-01-01 → 2023-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 20.4% | 2022-01-01 → 2022-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 28.7% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 31.2% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 20.4% | 2019-01-01 → 2019-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 345 | at 2023-12-31 | Cons. | Number of employees |
| Employees | 277 | at 2022-12-31 | Cons. | Number of employees |
| Employees | 161 | at 2021-12-31d | Cons. | Number of employees |
| Employees | 124 | at 2020-12-31d | Cons. | Number of employees |
| Employees | 105 | at 2019-12-31d | Cons. | Number of employees |
| Revenue | ¥7.5bn | 2023-01-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥8.2bn | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥7.3bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥5.2bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.3bn | 2019-01-01 → 2019-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.1bn | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Operating income | ¥2.7bn | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Ordinary income | ¥2.1bn | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.7bn | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.4bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥615m | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.2bn | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.4bn | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Net income | ¥1.5bn | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | ¥1.6bn | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | ¥1.5bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥926m | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥470m | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥13.0bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥12.3bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥10.5bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥5.4bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.1bn | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥2.0bn | at 2023-12-31 | Standalone | Liabilities |
| Total liabilities | ¥2.5bn | at 2022-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥11.0bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥9.8bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥8.1bn | at 2021-12-31d | Standalone | Net assets |
| Net assets / equity | ¥3.2bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥2.2bn | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥7.7bn | at 2023-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥7.0bn | at 2022-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥32.98 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.04 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.5 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.29 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.1 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥12 | 2023-01-01 → 2023-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥6 | 2022-01-01 → 2022-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥6 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥2 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥1.5 | 2019-01-01 → 2019-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥247.11 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥219.94 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥183.84 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥77.15 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥52.32 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 84.7% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.7% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.4% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.3% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.4% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 14.1% | 2023-01-01 → 2023-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 18.3% | 2022-01-01 → 2022-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 26.4% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 34.4% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 21.3% | 2019-01-01 → 2019-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 46,872,000 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 46,872,000 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 46,872,000 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,048,000 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,048,000 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 182 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 173 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 147 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 120 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 105 | at 2019-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2023-01-01 → 2023-12-31 | ¥42m |
| Reconciling Itemsreconciling | depreciation | 2023-01-01 → 2023-12-31 | ¥58m |
| Reconciling Itemsreconciling | segment assets | at 2023-12-31 | ¥14.1bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-12-31 | −¥1.8bn |
| Medical Degital Transformation Businessreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥19m |
| Medical Degital Transformation Businessreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥20m |
| Medical Degital Transformation Businessreportable segment | employees | at 2023-12-31 | 231 pure |
| Medical Degital Transformation Businessreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥9.2bn |
| Medical Degital Transformation Businessreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥9.2bn |
| Medical Degital Transformation Businessreportable segment | segment assets | at 2023-12-31 | ¥78m |
| Medical Degital Transformation Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥3.9bn |
| Medical Platform Businessreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥298m |
| Medical Platform Businessreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥607,000 |
| Medical Platform Businessreportable segment | employees | at 2023-12-31 | 67 pure |
| Medical Platform Businessreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥1.1bn |
| Medical Platform Businessreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥1.1bn |
| Medical Platform Businessreportable segment | segment assets | at 2023-12-31 | ¥10m |
| Medical Platform Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥264m |
| —segment total | capex | 2023-01-01 → 2023-12-31 | ¥317m |
| —segment total | depreciation | 2023-01-01 → 2023-12-31 | ¥21m |
| —segment total | revenue | 2023-01-01 → 2023-12-31 | ¥10.2bn |
| —segment total | revenue external | 2023-01-01 → 2023-12-31 | ¥10.2bn |
| —segment total | segment assets | at 2023-12-31 | ¥88m |
| —segment total | segment profit | 2023-01-01 → 2023-12-31 | ¥4.2bn |
| Reconciling Itemsreconciling | capex | 2022-01-01 → 2022-12-31 | ¥35m |
| Reconciling Itemsreconciling | depreciation | 2022-01-01 → 2022-12-31 | ¥57m |
| Reconciling Itemsreconciling | segment assets | at 2022-12-31 | ¥13.0bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | −¥1.6bn |
| Medical Degital Transformation Businessreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥984m |
| Medical Degital Transformation Businessreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥13m |
| Medical Degital Transformation Businessreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥8.5bn |
| Medical Degital Transformation Businessreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥8.5bn |
| Medical Degital Transformation Businessreportable segment | segment assets | at 2022-12-31 | ¥113m |
| Medical Degital Transformation Businessreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥4.2bn |
| Medical Platform Businessreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥265,000 |
| Medical Platform Businessreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥1m |
| Medical Platform Businessreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥854m |
| Medical Platform Businessreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥854m |
| Medical Platform Businessreportable segment | segment assets | at 2022-12-31 | ¥2m |
| Medical Platform Businessreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥228m |
| —segment total | capex | 2022-01-01 → 2022-12-31 | ¥984m |
| —segment total | depreciation | 2022-01-01 → 2022-12-31 | ¥15m |
| —segment total | revenue | 2022-01-01 → 2022-12-31 | ¥9.3bn |
| —segment total | revenue external | 2022-01-01 → 2022-12-31 | ¥9.3bn |
| —segment total | segment assets | at 2022-12-31 | ¥115m |
| —segment total | segment profit | 2022-01-01 → 2022-12-31 | ¥4.4bn |
| Medical Degital Transformation Businessreportable segment | employees | at 2023-12-31 | 114 pure |
| Medical Platform Businessreportable segment | employees | at 2023-12-31 | 21 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,514
| Item | Context | Value | Unit |
|---|---|---|---|
| Share based compensation expenses ope cf | Prior1YearDuration | 69265000 | JPY |
| Share based compensation expenses ope cf | CurrentYearDuration | 162423000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YearDuration | -4036000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYearDuration | 384000 | JPY |
| Increase decrease in provision for directors bonuses ope cf | Prior1YearDuration | -98628000 | JPY |
| Increase decrease in provision for directors bonuses ope cf | CurrentYearDuration | -135871000 | JPY |
| Increase decrease in provision for point card certificates ope cf | Prior1YearDuration | 237979000 | JPY |
| Increase decrease in provision for point card certificates ope cf | CurrentYearDuration | 32732000 | JPY |
| Increase decrease in provision for share based remuneration for directors and other officers ope cf | Prior1YearDuration | 21672000 | JPY |
| Increase decrease in provision for share based remuneration for directors and other officers ope cf | CurrentYearDuration | 21672000 | JPY |
| Increase decrease in provision for directors retirement benefits ope cf | Prior1YearDuration | － | JPY |
| Increase decrease in provision for directors retirement benefits ope cf | CurrentYearDuration | -5250000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1YearDuration | － | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYearDuration | 7084000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YearDuration | -226000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYearDuration | － | JPY |
| Interest and dividends income ope cf | Prior1YearDuration | -9244000 | JPY |
| Interest and dividends income ope cf | CurrentYearDuration | -9232000 | JPY |
| Interest expenses ope cf | Prior1YearDuration | 549000 | JPY |
| Interest expenses ope cf | CurrentYearDuration | 717000 | JPY |
| Foreign exchange losses gains ope cf | Prior1YearDuration | -14061000 | JPY |
| Foreign exchange losses gains ope cf | CurrentYearDuration | -8232000 | JPY |
| Equity in earnings losses of affiliates ope cf | Prior1YearDuration | － | JPY |
| Equity in earnings losses of affiliates ope cf | CurrentYearDuration | -28368000 | JPY |
| Loss gain on valuation of investment securities ope cf | Prior1YearDuration | 134220000 | JPY |
| Loss gain on valuation of investment securities ope cf | CurrentYearDuration | 35000000 | JPY |
| Loss gain on sales of subsidiaries stocks ope cf | Prior1YearDuration | － | JPY |
| Loss gain on sales of subsidiaries stocks ope cf | CurrentYearDuration | -5069000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YearDuration | -490646000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYearDuration | 115336000 | JPY |
| Decrease increase in inventories ope cf | Prior1YearDuration | 8368000 | JPY |
| Decrease increase in inventories ope cf | CurrentYearDuration | -6876000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YearDuration | 28256000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYearDuration | 73946000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YearDuration | 92009000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYearDuration | -199103000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | Prior1YearDuration | -86271000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | CurrentYearDuration | -11338000 | JPY |
| Increase decrease in accrued expenses ope cf | Prior1YearDuration | -8976000 | JPY |
| Increase decrease in accrued expenses ope cf | CurrentYearDuration | 15050000 | JPY |
| Increase decrease in advances received ope cf | Prior1YearDuration | 32192000 | JPY |
| Increase decrease in advances received ope cf | CurrentYearDuration | 23827000 | JPY |
| Other net ope cf | Prior1YearDuration | 2322000 | JPY |
| Other net ope cf | CurrentYearDuration | -53489000 | JPY |
| Subtotal ope cf | Prior1YearDuration | 2778726000 | JPY |
| Subtotal ope cf | CurrentYearDuration | 2718621000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YearDuration | 8440000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYearDuration | 8336000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YearDuration | -549000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYearDuration | -717000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |